Our locations are open for appointments and procedures. See how we're providing safe in-person care and telemedicine visits.

(Nuestras facilidades están abiertas para citas y procedimientos. Vea cómo brindamos atención segura en persona y visitas por medio de telemedicina.)

Learn More (Aprenda Más)
800-TEMPLE-MED Schedule Appointment

Media Coverage of First-in-Human Trial Results of Bashir Endovascular Catheter

View All News

Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, along with Nicholas Green, Director of Research & Development at Thrombolex, Inc., developed two catheters that received U.S. Food and Drug Administration premarket notification clearance last year. Now, the results of a first-in-human trial confirm early safety and feasibility of the Bashir Endovascular Catheter for pharmacomechanical catheter-directed thrombolysis in patients with acute pulmonary embolism. Endovascular Today, Venous News and TCTMD covered the announcement.